Zenas BioPharma (ZBIO) Other Working Capital Changes (2023 - 2026)
Zenas BioPharma (ZBIO) posted quarterly Other Working Capital Changes of -$211000.0 for Q1 2026, up 4.95% year-over-year from -$201038.6 in Q1 2025, and up 13.88% quarter-over-quarter from -$245000.0 in Q4 2025.
Zenas BioPharma (ZBIO) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Zenas BioPharma's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$211000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 4.95% year-over-year to -$211000.0; the TTM figure through Mar 2026 stood at -$891000.0 (down 21.89% YoY), while the FY2025 annual figure was -$902000.0, down 34.03% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$211000.0, up from -$245000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $8.2 million in Q4 2024, with the low at -$1.8 million in Q3 2024.
- The 4-year median for Other Working Capital Changes is $977000.0 (2025), against an average of $1.6 million.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes sank 70.16% in 2025, then increased 4.95% in 2026.
- Zenas BioPharma's Other Working Capital Changes stood at -$151000.0 in 2023, then plunged by 61.59% to -$244000.0 in 2024, then fell by 0.41% to -$245000.0 in 2025, then climbed by 13.88% to -$211000.0 in 2026.
- Business Quant data shows ZBIO's Other Working Capital Changes at -$211000.0 in Q1 2026, -$245000.0 in Q4 2025, and -$211000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zenas BioPharma | 1.87 Bn | 748.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.11 Mn |
| Jun 30, 2026 | -1.11 Mn |
| Jun 30, 2026 | -1.11 Mn |
| Mar 31, 2026 | 6.48 Mn |
| Mar 31, 2026 | 6.48 Mn |
| Mar 31, 2026 | 6.48 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | -1.16 Mn |
| Mar 31, 2025 | 353,000.00 |
| Mar 31, 2025 | 353,000.00 |
| Mar 31, 2025 | 353,000.00 |
| Dec 31, 2024 | 8.18 Mn |
| Dec 31, 2024 | 8.18 Mn |